GB9311030D0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
GB9311030D0
GB9311030D0 GB939311030A GB9311030A GB9311030D0 GB 9311030 D0 GB9311030 D0 GB 9311030D0 GB 939311030 A GB939311030 A GB 939311030A GB 9311030 A GB9311030 A GB 9311030A GB 9311030 D0 GB9311030 D0 GB 9311030D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939311030A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to GB939311030A priority Critical patent/GB9311030D0/en
Publication of GB9311030D0 publication Critical patent/GB9311030D0/en
Priority to PCT/IB1994/000204 priority patent/WO1994027600A1/en
Priority to EP94918998A priority patent/EP0675716A1/en
Pending legal-status Critical Current

Links

GB939311030A 1993-05-28 1993-05-28 Pharmaceutical formulations Pending GB9311030D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB939311030A GB9311030D0 (en) 1993-05-28 1993-05-28 Pharmaceutical formulations
PCT/IB1994/000204 WO1994027600A1 (en) 1993-05-28 1994-05-16 Pharmaceutical formulations with clavulanic acid and an antimycobacterial agent
EP94918998A EP0675716A1 (en) 1993-05-28 1994-05-16 Pharmaceutical formulations with clavulanic acid and an antimycobacterial agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939311030A GB9311030D0 (en) 1993-05-28 1993-05-28 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
GB9311030D0 true GB9311030D0 (en) 1993-07-14

Family

ID=10736272

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939311030A Pending GB9311030D0 (en) 1993-05-28 1993-05-28 Pharmaceutical formulations

Country Status (3)

Country Link
EP (1) EP0675716A1 (en)
GB (1) GB9311030D0 (en)
WO (1) WO1994027600A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ318282A (en) 1995-09-07 2000-01-28 Smithkline Beecham Corp Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
AR031068A1 (en) * 1999-04-13 2003-09-10 Beecham Pharm Pte Ltd A PHARMACEUTICAL FORMULATION OF MODIFIED RELEASE THAT INCLUDES AMOXICILLIN AND POTASSIUM CLAVULANATE IN A RATIO OF 2: 1 TO 20: 1, A COMPRESSED IN LAYERS, THE USE OF AMOXYCLINE AND THE POTASSIUM CLAVULANATE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT COMPACT GRANULES
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin

Also Published As

Publication number Publication date
WO1994027600A1 (en) 1994-12-08
EP0675716A1 (en) 1995-10-11

Similar Documents

Publication Publication Date Title
ZA953236B (en) Pharmaceutical formulations
ZA951781B (en) Pharmaceutical formulations
GB9323399D0 (en) Pharmaceutical formulations
GB9311030D0 (en) Pharmaceutical formulations
GB9201639D0 (en) Pharmaceutical formulations
GB9413542D0 (en) Pharmaceutical formulations
GB9304799D0 (en) Pharmaceutical formulations
GB9321676D0 (en) Pharmaceutical formulations
GB9301250D0 (en) Pharmaceutical formulations
GB9315119D0 (en) Pharmaceutical formulations
GB9314443D0 (en) Pharmaceutical formulations
GB9312344D0 (en) Pharmaceutical formulations
GB9304800D0 (en) Pharmaceutical formulations
GB9304797D0 (en) Pharmaceutical formulations
GB9302908D0 (en) Pharmaceutical formulations
GB9203212D0 (en) Pharmaceutical formulations
GB9307003D0 (en) Pharmaceutical formulations
GB9221244D0 (en) Pharmaceutical formulations
GB9217602D0 (en) Pharmaceutical formulations
GB9204774D0 (en) Pharmaceutical formulations
GB9207338D0 (en) Pharmaceutical formulations
GB9316253D0 (en) Pharmaceutical formulation
GB9305439D0 (en) Pharmaceutical formulation
GB9322907D0 (en) Pharmaceutical formulation
GB9322906D0 (en) Pharmaceutical formulation